시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
세계의 정맥성 다리 궤양 치료 시장 보고서(2025년)
Venous Leg Ulcer Treatment Global Market Report 2025
상품코드 : 1731059
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,183,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 8,938,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 11,692,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

정맥성 다리 궤양 치료 시장 규모는 향후 수 년간 강력한 성장이 전망될 예정입니다. 예측 기간 동안의 예상 성장은 의료비 지출 증가, 연구 개발 노력 증가, 당뇨병 사례 증가, 압박 요법 제품에 대한 수요 증가, 개인 맞춤형 상처 치료 솔루션에 대한 필요성 확대에 기인하고 있습니다.

의료시설의 확대가 정맥성 다리 궤양 치료 시장의 성장을 견인할 것으로 예측됩니다. 의료 시설은 효과적인 의료 서비스를 제공하는 데 필요한 필수적인 물리적 인프라, 시스템 및 자원을 포함합니다. 건강 관리 인프라의 성장은 주로 의료 기술의 진보로 이어집니다. 원격 의료, 로봇 수술, AI 기반 진단과 같은 혁신은 환자 치료와 효율성을 향상시키기 위해 업그레이드된 시설, 전문 장비, 개선된 의료 서비스 제공 시스템을 필요로 하기 때문입니다. 정교한 의료 종사자, 혁신적인 치료 옵션에 대한 액세스를 확보함으로써 정맥성 다리 궤양 치료에 중요한 역할을 담당하고 있습니다. 예를 들어, 미국에 본사를 둔 비영리 단체인 미국 병원 협회에 따르면 미국의 총 병원 수는 2022년 6,093개에서 2024년 6,120개로 증가했습니다.

정맥성 다리 궤양 치료 시장의 주요 기업은 치유를 개선하고 만성 상처 관리를 강화하기 위해 생합성 셀룰로오스를 이용한 선진 상처 드레싱를 개발하고 있습니다. 발효에 의해 생산되는 생물공학적 재료이며, 다양한 의료 용도에 고순도, 생체 적합성, 우수한 구조적 무결성을 제공합니다. Evonik Industries AG는 2023년 6월 정맥성 다리 궤양, 당뇨병성 발궤양, 욕창 등의 만성 상처 치료용으로 설계된 생합성 셀룰로오스제의 상처 피복 Epicite Balance를 발표했습니다. 이 드레싱재는 습윤한 상처 환경을 유지해, 삼출액을 흡수해, 뛰어난 세정 효과를 발휘하는 것으로 상처 치유를 서포트해, 병원과 재택 케어의 양쪽 모두에 적합합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Venous leg ulcer treatment encompasses a comprehensive approach to managing and healing open sores that develop on the legs due to poor venous circulation. This treatment typically includes compression therapy to enhance blood flow, wound care to prevent infections, and medical or lifestyle interventions to address underlying venous conditions.

The primary treatment methods for venous leg ulcers include compression therapy, debridement, medication, and surgery. Compression therapy is a non-invasive approach that applies pressure to the affected leg to improve circulation, reduce swelling, and promote healing while preventing recurrence. The condition can stem from various etiologies, including venous insufficiency, arterial insufficiency, and mixed insufficiency. Treatment mechanisms involve oxygenation enhancers, growth factor stimulators, anti-inflammatory agents, and antimicrobial therapies. These treatments are utilized across various settings, including hospitals, clinics, home healthcare, and other medical facilities.

The venous leg ulcer treatment market research report is one of a series of new reports from The Business Research Company that provides venous leg ulcer treatment market statistics, including venous leg ulcer treatment industry global market size, regional shares, competitors with a venous leg ulcer treatment market share, detailed venous leg ulcer treatment market segments, market trends and opportunities, and any further data you may need to thrive in the venous leg ulcer treatment industry. This venous leg ulcer treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The venous leg ulcer treatment market size has grown strongly in recent years. It will grow from $4.00 billion in 2024 to $4.30 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth during the historic period can be attributed to the rising prevalence of venous leg ulcers, greater awareness of advanced wound care therapies, increasing preference for minimally invasive treatments, the expanded use of antimicrobial dressings, and the growing adoption of bioengineered skin substitutes.

The venous leg ulcer treatment market size is expected to see strong growth in the next few years. It will grow to $5.68 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The projected growth during the forecast period can be attributed to rising healthcare expenditures, increased research and development efforts, a growing number of diabetes cases, higher demand for compression therapy products, and the expanding need for personalized wound care solutions. Key trends expected in this period include advancements in wound dressings, innovations in compression therapy, the integration of telemedicine, the use of artificial intelligence (AI) for wound assessment, and the expansion of health insurance coverage.

The expansion of healthcare facilities is expected to drive the growth of the venous leg ulcer treatment market. Healthcare facilities encompass the essential physical infrastructure, systems, and resources required to provide effective medical services. The growth of healthcare infrastructure is primarily driven by advancements in medical technology, as innovations such as telemedicine, robotic surgery, and AI-driven diagnostics necessitate upgraded facilities, specialized equipment, and improved healthcare delivery systems to enhance patient care and efficiency. These healthcare facilities play a crucial role in venous leg ulcer treatment by ensuring access to modern wound care technologies, evidence-based therapies, skilled medical professionals, and innovative treatment options, all of which contribute to better healing outcomes and an improved quality of life for patients. For example, according to the American Hospital Association, a US-based non-profit organization, the total number of hospitals in the United States reached 6,120 in 2024, increasing from 6,093 in 2022. As a result, the ongoing expansion of healthcare infrastructure is fueling the growth of the venous leg ulcer treatment market.

Leading companies in the venous leg ulcer treatment market are developing advanced wound dressings utilizing biosynthetic cellulose to improve healing and enhance chronic wound management. Biosynthetic cellulose is a bioengineered material produced by microorganisms through fermentation, offering high purity, biocompatibility, and excellent structural integrity for various medical applications. For instance, in June 2023, Evonik Industries AG, a Germany-based specialty chemicals company, introduced Epicite Balance, a wound dressing made from biosynthetic cellulose designed for the treatment of chronic wounds such as venous leg ulcers, diabetic foot ulcers, and pressure ulcers. This dressing supports wound healing by maintaining a moist wound environment, absorbing exudate, and facilitating superior cleansing, making it suitable for both hospital and homecare use.

In June 2022, Healiva SA, a Switzerland-based company specializing in comprehensive chronic wound care solutions, acquired two wound-healing cell therapy assets from Smith+Nephew plc for an undisclosed amount. This acquisition allowed Healiva SA to enhance its portfolio by integrating advanced cell therapy solutions for chronic wound care. Smith+Nephew plc, a UK-based medical technology company, provides venous leg ulcer treatment solutions.

Major players in the venous leg ulcer treatment market are 3M Healthcare, Essity AB, B. Braun Melsungen AG, Smith & Nephew plc, Coloplast A/S, Convatec Group PLC, Molnlycke Healthcare, Integra LifeSciences, Hollister Incorporated, Bioventus LLC, Medi, Kerecis, HSE.ie, Tissue Regenix Group, The Whiteley Clinic, Huntleigh Healthcare, Derma Sciences, Systagenix Wound Management, Kinetic Concepts, and Orpyx Medical Technologies

North America was the largest region in the venous leg ulcer treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in venous leg ulcer treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the venous leg ulcer treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The venous leg ulcer treatment market consists of revenues earned by entities by providing services such as infection management, and skin grafting. The market value includes the value of related goods sold by the service provider or included within the service offering. The venous leg ulcer treatment market also includes sales of compression stockings, foam dressings, skin protectants, debridement tools, and hydrocolloid dressings. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Venous Leg Ulcer Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on venous leg ulcer treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for venous leg ulcer treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The venous leg ulcer treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Venous Leg Ulcer Treatment Market Characteristics

3. Venous Leg Ulcer Treatment Market Trends And Strategies

4. Venous Leg Ulcer Treatment Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Venous Leg Ulcer Treatment Growth Analysis And Strategic Analysis Framework

6. Venous Leg Ulcer Treatment Market Segmentation

7. Venous Leg Ulcer Treatment Market Regional And Country Analysis

8. Asia-Pacific Venous Leg Ulcer Treatment Market

9. China Venous Leg Ulcer Treatment Market

10. India Venous Leg Ulcer Treatment Market

11. Japan Venous Leg Ulcer Treatment Market

12. Australia Venous Leg Ulcer Treatment Market

13. Indonesia Venous Leg Ulcer Treatment Market

14. South Korea Venous Leg Ulcer Treatment Market

15. Western Europe Venous Leg Ulcer Treatment Market

16. UK Venous Leg Ulcer Treatment Market

17. Germany Venous Leg Ulcer Treatment Market

18. France Venous Leg Ulcer Treatment Market

19. Italy Venous Leg Ulcer Treatment Market

20. Spain Venous Leg Ulcer Treatment Market

21. Eastern Europe Venous Leg Ulcer Treatment Market

22. Russia Venous Leg Ulcer Treatment Market

23. North America Venous Leg Ulcer Treatment Market

24. USA Venous Leg Ulcer Treatment Market

25. Canada Venous Leg Ulcer Treatment Market

26. South America Venous Leg Ulcer Treatment Market

27. Brazil Venous Leg Ulcer Treatment Market

28. Middle East Venous Leg Ulcer Treatment Market

29. Africa Venous Leg Ulcer Treatment Market

30. Venous Leg Ulcer Treatment Market Competitive Landscape And Company Profiles

31. Venous Leg Ulcer Treatment Market Other Major And Innovative Companies

32. Global Venous Leg Ulcer Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Venous Leg Ulcer Treatment Market

34. Recent Developments In The Venous Leg Ulcer Treatment Market

35. Venous Leg Ulcer Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기